{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04537403",
            "orgStudyIdInfo": {
                "id": "201911199"
            },
            "organization": {
                "fullName": "Washington University School of Medicine",
                "class": "OTHER"
            },
            "briefTitle": "PET Detection of CCR2 in Human Atherosclerosis",
            "officialTitle": "PET Detection of CCR2 in Human Atherosclerosis",
            "therapeuticArea": [
                "Other"
            ],
            "study": "pet-detection-of-in-human-atherosclerosis"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-12",
            "overallStatus": "RECRUITING",
            "startDateStruct": {
                "date": "2020-10-01",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-09-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-09-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2020-08-17",
            "studyFirstSubmitQcDate": "2020-08-28",
            "studyFirstPostDateStruct": {
                "date": "2020-09-03",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-12-04",
            "lastUpdatePostDateStruct": {
                "date": "2023-12-05",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Washington University School of Medicine",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": ": Use of novel radio-pharmaceutical 64CUDOTA-ECL1i to evaluate arterial atherosclrosis",
            "detailedDescription": "Using 64CUDOTA-ECL1i to evaluate arterial atherosclrosis in normal volunteers and patients with carotid or femoral arterial atherosclerosis.."
        },
        "conditionsModule": {
            "conditions": [
                "Carotid Atherosclerosis"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "DIAGNOSTIC",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 100,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Aim 1A",
                    "type": "EXPERIMENTAL",
                    "description": "Normal volunteers and patients with Carotid and Femoral Atherosclerosis who will be having surgery",
                    "interventionNames": [
                        "Drug: Group 1-64CU-DOTA-ECL1i (radioactive imaging medicine)"
                    ]
                },
                {
                    "label": "Aim 1B",
                    "type": "EXPERIMENTAL",
                    "description": "Patients with Carotid and Femoral Atherosclerosis who will be managed medically and not having surgery",
                    "interventionNames": [
                        "Drug: Group 2 64CU-DOTA-ECL1i (radioactive imaging medicine)"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Group 1-64CU-DOTA-ECL1i (radioactive imaging medicine)",
                    "description": "Patients in Group 1, normal volunteers and patients with carotid and femoral artery disease who will be having surgery, will have a 1 day imaging session lasting approximately 60 minutes with an injection of 64CU-DOTA-ECL1i to visualize the carotid and femoral arteries. Patients with carotid and femoral artery disease will have their plaque specimens collected for further sutdy",
                    "armGroupLabels": [
                        "Aim 1A"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Group 2 64CU-DOTA-ECL1i (radioactive imaging medicine)",
                    "description": "Patients in Group 2, who are patients with carotid and femoral artery disease who will not be having surgery will have two imaging sessions 7-14 days apart",
                    "armGroupLabels": [
                        "Aim 1B"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Evaluation of 64CU-ECL1i , imaging characteristics",
                    "description": "Injecting normal volunteers and patients who have blocked arteries with a single bolus injection. The dose of the injection is 8-10, and the above drug is measured in millicuries, which is a unit of radioactivity.\n\nthe dose of millicuries will be 8-10 millicures",
                    "timeFrame": "1 or 2 days"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "PET/MR camera, imaging performance",
                    "description": "Utilizing the PET/MR camera using audiography, which can show the presence and size of the blockage",
                    "timeFrame": "1-2 days"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria: Normal Volunteers: 18-40 years of age, non smoker, no history of diabetes, hypertension, or hyperlipidemia. Patients: 50-89 years of age, adequate nutritional status, with or without smoking history, diabetes, hypertension, and hyperlipidema. Both asymptomatic and symptomatic patients with known carotid artery atherosclrosis \\>70% and scheduled to undergo surgery. Advanced peripheral artery disease.\n\n-\n\nExclusion Criteria:Inability to receive and sign informed consent. Currently enrolled in another study. Patients who have type 1 diabetes or are in septic shock, receiving steroid therapy, recent history of heavy alcohol consumption, (male \\>2 drinks per day, and female \\> 1 drink per day. following extreme diets like Atkins or South Beach diet or with Stage 4 chronic renal failure. Patients with unstable clinical condition that in the opinion of the PI precludes participation in the study. Inability to tolerate 60 minutes in a supine position with arms down at sides. Contraindications to MR imaging, (pacemaker, brain aneurysm clips, shrapnel, etc. Positive pregnancy test or lactating. Have another conditions such as cancer or autoimmune/inflammatory diseases, e.g. rheumatoid arthritis or multiple sclerosis that are known to have increased expression of CCR2.\n\n-",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "89 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Kitty Harrison, BSN, RN",
                    "role": "CONTACT",
                    "phone": "314-747-0183",
                    "email": "harrisonk@mir.wustl.edu"
                },
                {
                    "name": "Robert Gropler, M.D.",
                    "role": "CONTACT",
                    "phone": "314-747-0183",
                    "email": "groplerr@mir.wustl.edu"
                }
            ],
            "locations": [
                {
                    "facility": "Washington University CCIR",
                    "status": "RECRUITING",
                    "city": "Saint Louis",
                    "state": "Missouri",
                    "zip": "63110",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Molly Mohrman",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.62727,
                        "lon": -90.19789
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000002340",
                    "term": "Carotid Artery Diseases"
                },
                {
                    "id": "D000050197",
                    "term": "Atherosclerosis"
                }
            ],
            "ancestors": [
                {
                    "id": "D000001161",
                    "term": "Arteriosclerosis"
                },
                {
                    "id": "D000001157",
                    "term": "Arterial Occlusive Diseases"
                },
                {
                    "id": "D000014652",
                    "term": "Vascular Diseases"
                },
                {
                    "id": "D000002318",
                    "term": "Cardiovascular Diseases"
                },
                {
                    "id": "D000002561",
                    "term": "Cerebrovascular Disorders"
                },
                {
                    "id": "D000001927",
                    "term": "Brain Diseases"
                },
                {
                    "id": "D000002493",
                    "term": "Central Nervous System Diseases"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M26188",
                    "name": "Atherosclerosis",
                    "asFound": "Atherosclerosis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5594",
                    "name": "Carotid Artery Diseases",
                    "asFound": "Carotid Atherosclerosis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4469",
                    "name": "Arteriosclerosis",
                    "relevance": "LOW"
                },
                {
                    "id": "M4465",
                    "name": "Arterial Occlusive Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17400",
                    "name": "Vascular Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5810",
                    "name": "Cerebrovascular Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M5204",
                    "name": "Brain Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5742",
                    "name": "Central Nervous System Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "C000071349",
                    "term": "1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid"
                }
            ],
            "ancestors": [
                {
                    "id": "D000002614",
                    "term": "Chelating Agents"
                },
                {
                    "id": "D000064449",
                    "term": "Sequestering Agents"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M254721",
                    "name": "1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid",
                    "asFound": "Zone",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5860",
                    "name": "Chelating Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}